# DESCRIPTION

## BACKGROUND

## SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION

### Antigen-Binding Constructs

### Testing of Antigen-Binding Constructs: HER2 Binding

### Reference Antigen-Binding Construct

### Antigen-Binding Constructs and Antibody Drug Conjugates (ADC)

### Methods of Preparation of Antigen-Binding Constructs

### Pharmaceutical Compositions

### Methods of Treatment

### Kits and Articles of Manufacture

## EXAMPLES

### Example 1: Affinity-Improved Anti-HER2 Antibodies Based on Pertuzumab

### Example 2: Preparation of Variant Antigen-Binding Constructs with Improved Affinity for HER2

### Example 3: Affinity of Variant Antigen-Binding Constructs as Measured by Surface Plasmon Resonance

### Example 4: Measurement of Thermal Stability of Variant Antigen-Binding Constructs by Differential Scanning Calorimetry

### Example 5: Measurement of Binding Affinity of a Variant Antigen-Binding Construct in FSA Format to Whole Cells by Flow Cytometry

### Example 6: Ability of a Variant Antigen-Binding Construct in FSA Format to Inhibit Cell Growth

### Example 7: Assessment of Affinity of Literature Pertuzumab Variants for HER2 by SPR

### Example 8: Design and Preparation of Combination Variant Antigen-Binding Constructs Based on Selected 1X Amino Acid Substitution Variants, and Measurement of Affinity for ECD2 of HER2 by SPR

### Example 9: Measurement of Thermal Stability of Selected Combination Variant Antigen-Binding Constructs by Differential Scanning Calorimetry (DSC)

